An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 16 May 2013.
If you wish to oppose the grant of a patent, or if your grant own application has been opposed by third parties, please contact us.
Please note that the information in the tables below is correct as at the date of the Patent Office Journal but is subject to change. Please check AUSPAT for the current status of any of the patents below.
Opposition Proceedings
Opposition Lodged
Acceptance of the following patent applications has been opposed:
| Application No. | Title | Applicant(s) | Opponent(s) |
| 2007311493 | Multiple unit tablet compositions of benzimidazole compounds | Ranbaxy Laboratories Limited | Generic Partners |
| 2008314093 | Multilayer body and method for producing a multilayer body | OVD Kinegram AG | Innovia Security Pty Ltd |
| 2009200048 | Marine power distribution and propulsion systems | Converteam Technology Ltd | SIEMENS AG |
Opposition Withdrawn
Opposition to acceptance of the following applications has been withdrawn and the application shall proceed to sealing:
| Application No. | Title | Applicant(s) | Opponent(s) |
| 2006323849 | Method for preparing a factor H concentrate and the use thereof in the form of a drug | Laboratoire Francais du Fractionnement et des Biotechnologies Societe Anonyme | Borovec, S. |
| 2008314093 | Immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies and of polyreactive IgGs | Laboratoire Francais du Fractionnement et des Biotechnologies Societe Anonyme | Borovec, S. |
Opposition Dismissed
No additional opposition proceedings have been dismissed.
Applications Withdrawn
No additional Applications for Opposition have been withdrawn.
Extensions of Term of Standard Patents
Applications Filed
The following application(s) for Extension of Term under Section 70 have been made:
| Patent No. | Title | Applicant | Approval Date & Goods |
| 2001268427 | Antibodies that immunospecifically bind to blys | Human Genome Sciences, Inc. | 18 October 2012For the goods BENLYSTA belimumab |
| 2003237886 | C-aryl glucoside SGLT2 inhibitors and method | Bristol-Myers Squibb Company | 22 October 2012For the goods FORXIGA dapagliflozin |
Applications Accepted
No additional application(s) for Extension of Term have been accepted under Section 74.
Applications Refused
No additional application(s) for Extension of Term have been refused.
Extensions granted
No additional application(s) for Extension of Term have been granted.
Surrendered and Revoked Letters Patent
Surrendered Letters Patent
No patents have been offered for surrender.
Revocation of Letters Patent
The following patent has been wholly or partially revoked in accordance with Section 137:
| Patent No. | Title | Patentee | Date of Patent |
| 2009216908 | Stabilization of dehydrogenases using stable coenzymes | F. Hoffmann – La Roche AG | 28 March 2013 |